Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case–Control Study

Objectives: Interstitial lung disease (ILD) is an extra-articular manifestation in rheumatoid arthritis (RA), detected in 10.7% of patients, and causing a poor prognosis. Hence, biomarkers for ILD are urgently required in RA. Low molecular weight metabolites can be assessed by metabolomic analyses,...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Hiroshi, Oka, Shomi, Shimada, Kota, Okamoto, Akira, Hashimoto, Atsushi, Komiya, Akiko, Saisho, Koichiro, Yoshikawa, Norie, Katayama, Masao, Matsui, Toshihiro, Fukui, Naoshi, Migita, Kiyoshi, Tohma, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773768/
https://www.ncbi.nlm.nih.gov/pubmed/33392224
http://dx.doi.org/10.3389/fmed.2020.599794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773768/
https://www.ncbi.nlm.nih.gov/pubmed/33392224
http://dx.doi.org/10.3389/fmed.2020.599794

Ejemplares similares